Time-dependent alterations in serum NO concentration after oral administration of L-arginine, L-NAME, and allopurinol in intestinal ischemia/reperfusion

Vasc Health Risk Manag. 2008;4(2):437-41. doi: 10.2147/vhrm.s2433.

Abstract

Objective: To study the effect of oral administration of a nitric oxide (NO) donor L-arginine (L-Arg), a NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME) and an inhibitor of xanthine oxidase, allopurinol (Allo), on serum NO concentration and catalase activity after intestinal ischemia/reperfusion (I/R) in rats.

Methods: Male Wistar rats receivedper os L-Arg (800 mg/kg) or L-NAME (50 mg/kg) or Allo (100 mg/kg) 24 hrs, 12 hrs and 1 hr before underwent 1 hr occlusion of superior mesenteric artery followed by 1 hr of reperfusion (L-Arg(IR1), L-NAME(IR1) and Allo(IR1) respectively) or 1 hr occlusion followed by 8 hrs of reperfusion (L-Arg(IR8), L-NAME(IR8) and Allo(IR8) respectively). There was one group underwent 1 hr occlusion (I), a group underwent 1 hr occlusion followed by 1 hr reperfusion (IR1), a group subjected to 1 hr occlusion followed by 8 hrs of reperfusion (IR8) and a last group that served as control (C). Serum NO concentration and catalase activity were measured.

Results: After 1 hr of reperfusion serum NO concentration was elevated in IR1 and L-Arg(IR1) groups compared with group C but not in L-NAME(IR1) and Allo(IR1) group. Catalase activity was enhanced in L-NAME(IR1) group. Interestingly, serum NO concentration was increased after 8 hrs of reperfusion in all groups (IR8, L-Arg(IR8), L-NAME(IR8) and Allo(IR8)) compared with control while catalase activity did not show significant difference in any group.

Conclusions: The results of the present study show that NO concentration is elevated in serum after intestinal I/R and the elevation sustained after administration of L-Arg but not after administration of L-NAME or Allo after 1 hr reperfusion. However, after 8 hrs of reperfusion NO concentration was increased in all groups studied, focusing attention on its possible important role in a complicated situation such as intestinal I/R that involves intestine and other organs. Serum catalase activity does not seem to be affected by per os supplementation of L-Arg or Allo in intestinal I/R.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Allopurinol / administration & dosage*
  • Animals
  • Arginine / administration & dosage*
  • Catalase / blood
  • Disease Models, Animal
  • Enzyme Inhibitors / administration & dosage*
  • Intestinal Mucosa / metabolism
  • Intestines / blood supply
  • Intestines / drug effects*
  • Male
  • Mesenteric Artery, Superior
  • Mesenteric Vascular Occlusion / complications*
  • Mesenteric Vascular Occlusion / enzymology
  • Mesenteric Vascular Occlusion / metabolism
  • NG-Nitroarginine Methyl Ester / administration & dosage*
  • Nitric Oxide / blood*
  • Nitric Oxide Donors / administration & dosage*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / metabolism
  • Rats
  • Rats, Wistar
  • Reperfusion Injury / enzymology
  • Reperfusion Injury / etiology
  • Reperfusion Injury / metabolism*
  • Time Factors
  • Xanthine Oxidase / antagonists & inhibitors
  • Xanthine Oxidase / metabolism

Substances

  • Enzyme Inhibitors
  • Nitric Oxide Donors
  • Nitric Oxide
  • Allopurinol
  • Arginine
  • Catalase
  • Nitric Oxide Synthase
  • Xanthine Oxidase
  • NG-Nitroarginine Methyl Ester